Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05346848
Title A Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer (DARIUS)
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie
Indications

prostate cancer

Therapies

Darolutamide

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.